Rhabdoid tumor predisposition syndrome

SMARCB1 - Rhabdoid tumor predisposition syndrome type 1

This test is available for the following conditions:

• Conditions > Oncogenetics > Rhabdoid tumor predisposition syndrome

This product is also part of the following panels:

• WES hereditary cancer (100.0% *)
• WES intellectual disability (100.0% *)
• WES Mendelian inherited disorders (100.0% *)
• WES neurological pain disorders¹ (100.0% *)
• WES short stature/skeletal dysplasia (100.0% *)
• WES skin disorders¹ (100.0% *)
• WES sonic hedgehog medulloblastoma (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
3 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 601607
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA, Buccal mucous membrane

---